CBI registers case against two ESIC doctors for bribe

The CBI has registered a case against two doctors of the Insurance State Insurance Corporation (ESIC) Vikas Gupta and Kajal Gooler for allegedly demanding a bribe of Rs 1 crore from a person supplying drugs.

New Delhi: The CBI has booked two doctors for allegedly demanding a bribe of Rs one crore from a medicine supplier with the assurance of getting him listed as an agent of a noted pharmaceutical manufacturer under central rate contract, officials said Friday.

Vikas Gupta and Kajal Goldar, both medical officers of ESI Corporation, now posted at its hospitals in Tirunelveli and Kolhapur respectively, have been booked by the CBI for alleged criminal conspiracy, cheating and under provisions of the Prevention of Corruption Act, they said.

The action has been initiated on a complaint from the ESIC which conducted a vigilance probe against the two on a complaint from a Delhi-based medicine supplier.

It was alleged that during 2016-17 Gupta, then working as medical officer, and Goldar as Director(medical), Delhi, had allegedly induced the supplier to pay Rs one crore as bribe for awarding a contract in Central Rate Contract (CRC) of ESIC for supply of medicine and dressings by engaging him a agent of a reputed manufacturer during the process of ensuing tender for CRC.

Basant Goel, the supplier, allegedly paid Rs one crore to Gupta — Rs 38 lakh in his account, Rs 10 lakh in his wife’s account and another Rs 52 lakh in cash on various dates to be delivered to Goldar.

On receiving complaint from Goel, the ESIC conducted a vigilance inquiry which confirmed payment of Rs 48 lakh to Vikas Gupta and his wife Geeta Gera, the complaint from ESIC said.

“It has also been established that Kajal Goldar and Vikas Gupta had official dealings with Goel Medicos and Basant Goel, an empanelled chemist for supply of day to day medicines and drugs and dressings to various hospitals and dispensaries of Delhi and NCR. The saidchemist was allocated and was supplying medicines to VK Nagar dispensary of which Vikas Gupta was the IMO. Therefore Basant Goel has business interest and dealings as well as acquaintance with both the officers,” it said.

The ESIC also alleged suspicious high-value transactions in Gupta’s accounts and property dealings by him during 2013 and onwards for which no satisfactory explanation could be provided by him.

Related Posts

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

In a Trailblazing approach, Aakash Healthcare Surgeons rebuilt Children’s Lower Limbs using Mothers’ Bone New Delhi: A 16-year-old girl whose thigh bone was destroyed by chronic infection in 2021 is…

Safdarjung Hospital performs its first dual kidney transplant using organs from marginal donor

The Indian Air Force airlifted the retrieved organs to Delhi from Command Hospital, Chandimandir, where the 62-year-old donor was declared brain dead. New Delhi: Vardhman Mahavir Medical College (VMMC) and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction